Guardant Health
GH
#1124
Rank
A$30.57 B
Marketcap
A$226.01
Share price
-0.37%
Change (1 day)
51.03%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Annual Reports

Thumbnail Guardant Health
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report